A detailed history of N Verses Capital, LLC transactions in Mannkind Corp stock. As of the latest transaction made, N Verses Capital, LLC holds 18,100 shares of MNKD stock, worth $116,383. This represents 0.05% of its overall portfolio holdings.

Number of Shares
18,100
Holding current value
$116,383
% of portfolio
0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$5.01 - $6.7 $90,681 - $121,270
18,100 New
18,100 $114 Million
Q1 2024

Apr 25, 2024

BUY
$3.25 - $5.27 $36,400 - $59,023
11,200 New
11,200 $50.7 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.65B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.